Synthetic lethality: Targeting DNA repair mechanisms in clinical trials

被引：0
|
作者：
Tutt, Andrew [1 ]
机构：
[1] Kings Hlth Partners AHSC, Guys Hosp, Integrated Canc Ctr, London, England
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-PL04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL04-02
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Sensitization of human tumor cells to chemotherapy drugs by antisense downregulation of RAD51: Targeting DNA repair to induce synthetic lethality
    Ferguson, Peter J.
    Rytelewski, Mateusz
    Vincent, Mark D.
    Koropatnick, James
    CANCER RESEARCH, 2016, 76
  • [32] Targeting nucleotide excision repair: Chemical synthetic lethality and biology-based combination therapy
    Turchi, John J.
    Lee, Jiyoon
    Hendricks, Jeremiah
    Neher, Tracy M.
    Fitch, Richard W.
    CANCER RESEARCH, 2012, 72
  • [33] Can synthetic lethality approach be used with DNA repair genes for primary and secondary MDS?
    Ribeiro Junior, Howard Lopes
    Germano de Oliveira, Roberta Taiane
    Borges, Daniela de Paula
    Costa, Marilia Braga
    Farias, Izabelle Rocha
    Araujo dos Santos, Antonio Wesley
    Meira Magalhaes, Silvia Maria
    Pinheiro, Ronald Feitosa
    MEDICAL ONCOLOGY, 2019, 36 (12)
  • [34] Targeting Rb inactivation in cancers by synthetic lethality
    Gordon, Gabriel M.
    Du, Wei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2011, 1 (06): : 773 - 786
  • [35] Can synthetic lethality approach be used with DNA repair genes for primary and secondary MDS?
    Howard Lopes Ribeiro Junior
    Roberta Taiane Germano de Oliveira
    Daniela de Paula Borges
    Marília Braga Costa
    Izabelle Rocha Farias
    Antônio Wesley Araújo dos Santos
    Silvia Maria Meira Magalhães
    Ronald Feitosa Pinheiro
    Medical Oncology, 2019, 36
  • [36] TRANSCRIPTOME ASSESSMENT OF DNA REPAIR GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA: SYNTHETIC LETHALITY TARGETS
    Hurtado Lopez, A. M.
    Luengo Gil, G.
    Chen, T.
    Palomo, L.
    Lumbreras, E.
    Caparros, E.
    Przychodzen, B.
    Amigo, M. L.
    Diez-Campelo, M.
    Zamora, L.
    Ortuno, F.
    Vicente, V.
    Maciejewski, J.
    del Canizo, C.
    Sole, F.
    Ferrer-Marin, F.
    Jerez, A.
    HAEMATOLOGICA, 2017, 102 : 261 - 261
  • [37] Applying Synthetic Lethality for the Selective Targeting of Cancer
    McLornan, Donal P.
    List, Alan
    Mufti, Ghulam J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (18): : 1725 - 1735
  • [38] PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
    Chabanon, Roman M.
    Morel, Daphne
    Eychenne, Thomas
    Colmet-Daage, Leo
    Bajrami, Ilirjana
    Dorvault, Nicolas
    Garrido, Marlene
    Meisenberg, Cornelia
    Lamb, Andrew
    Ngo, Carine
    Hopkins, Suzanna R.
    Roumeliotis, Theodoros, I
    Jouny, Samuel
    Henon, Clemence
    Kawai-Kawachi, Asuka
    Astier, Clemence
    Konde, Asha
    Del Nery, Elaine
    Massard, Christophe
    Pettitt, Stephen J.
    Margueron, Raphael
    Choudhary, Jyoti S.
    Almouzni, Genevieve
    Soria, Jean-Charles
    Deutsch, Eric
    Downs, Jessica A.
    Lord, Christopher J.
    Postel-Vinay, Sophie
    CANCER RESEARCH, 2021, 81 (11) : 2888 - 2902
  • [39] Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targeting
    Ronson, George E.
    Starowicz, Katarzyna
    Anthony, Elizabeth J.
    Piberger, Ann Liza
    Clarke, Lucy C.
    Garvin, Alexander J.
    Beggs, Andrew D.
    Whalley, Celina M.
    Edmonds, Matthew J.
    Beesley, James F. J.
    Morris, Joanna R.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [40] Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targeting
    George E. Ronson
    Katarzyna Starowicz
    Elizabeth J. Anthony
    Ann Liza Piberger
    Lucy C. Clarke
    Alexander J. Garvin
    Andrew D. Beggs
    Celina M. Whalley
    Matthew J. Edmonds
    James F. J. Beesley
    Joanna R. Morris
    Nature Communications, 14
12345